EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Modeling of Retina and Optic Nerve Ischemia–Reperfusion Injury through Hypoxia–Reoxygenation in Human Induced Pluripotent Stem Cell-Derived Retinal Ganglion Cells

Tomoyo Yoshida, Tadashi Yokoi, Taku Tanaka, Emiko Matsuzaka, Yuki Saida, Sachiko Nishina, Shuji Takada, Shigeomi Shimizu iD, Noriyuki Azuma

Cells · 2024

DOI: 10.3390/cells13020130 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, 2024. Verfasst von Tomoyo Yoshida und 8 weiteren Autor:innen. Beteiligte Einrichtung: National Center for Child Health and Development, 2-10-1, O-kura, Setagaya-ku, Tokyo 1578535, Japan. Hauptthemen laut MEDLINE: Induced Pluripotent Stem Cells, Optic Neuropathy, Ischemic, Reperfusion Injury. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: JSPS KAKENHI, National Center for Child Health and Development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Retinal ganglion cells (RGCs) are specialized projection neurons that constitute part of the retina, and the death of RGCs causes various eye diseases, but the mechanism of RGC death is still unclear. Here, we induced cell death in human induced pluripotent stem cell (hiPSC)-derived RGC-rich retinal tissues using hypoxia–reoxygenation in vitro. Flow cytometry, immunochemistry, and Western blotting showed the apoptosis and necrosis of RGCs under hypoxia–reoxygenation, and they were rescued by an apoptosis inhibitor but not by a necrosis inhibitor. This revealed that the cell death induced in our model was mainly due to apoptosis. To our knowledge, this is the first model to reproduce ischemia–reperfusion in hiPSC-derived RGCs. Thus, the efficacy of apoptosis inhibitors and neuroprotective agents can be evaluated using this model, bringing us closer to clinical applications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Induced Pluripotent Stem CellsOptic Neuropathy, IschemicReperfusion InjuryHumansRetinal Ganglion CellsRetinaOptic NerveNecrosisHypoxia

Stichwörter der Autor:innen

apoptosishuman iPS cellshypoxia–reoxygenationischemia–reperfusionretinal ganglion cells

Autor:innen und Institutionen

  • National Center for Child Health and Development, 2-10-1, O-kura, Setagaya-ku, Tokyo 1578535, Japan.
  • Department of Pathological Cell Biology, Tokyo Medical and Dental University, 1-5-4, Yushima, Bunkyo-ku, Tokyo 1138510, Japan.
  • Department of ophthalmology, Kyorin University, 6-20-2, Arakawa, Mitaka, Tokyo 1818611, Japan.
  • Department of Developmental and Regenerative Biology, Tokyo Medical and Dental University, 1-5-4, Yushima, Bunkyo-ku, Tokyo 1138510, Japan.

ORCID-Profile: Shigeomi Shimizu

Förderung

  • JSPS KAKENHI
  • National Center for Child Health and Development

Zitieren

APA

Yoshida, T., Yokoi, T., Tanaka, T., Matsuzaka, E., Saida, Y., Nishina, S., Takada, S., Shimizu, S., & Azuma, N. (2024). Modeling of Retina and Optic Nerve Ischemia–Reperfusion Injury through Hypoxia–Reoxygenation in Human Induced Pluripotent Stem Cell-Derived Retinal Ganglion Cells. Cells. https://doi.org/10.3390/cells13020130

Vancouver

Yoshida T, Yokoi T, Tanaka T, Matsuzaka E, Saida Y, Nishina S, et al. Modeling of Retina and Optic Nerve Ischemia–Reperfusion Injury through Hypoxia–Reoxygenation in Human Induced Pluripotent Stem Cell-Derived Retinal Ganglion Cells. Cells. 2024. doi:10.3390/cells13020130

BibTeX
@article{Yoshida2024,
  author = {Yoshida, Tomoyo and Yokoi, Tadashi and Tanaka, Taku and Matsuzaka, Emiko and Saida, Yuki and Nishina, Sachiko and Takada, Shuji and Shimizu, Shigeomi and Azuma, Noriyuki},
  title = {Modeling of Retina and Optic Nerve Ischemia–Reperfusion Injury through Hypoxia–Reoxygenation in Human Induced Pluripotent Stem Cell-Derived Retinal Ganglion Cells},
  journal = {Cells},
  year = {2024},
  doi = {10.3390/cells13020130}
}
Kostenlos starten →